Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
We compared CSF and serum levels of iron, copper, manganese, and zinc, measured by atomic absorption spectrophotometry, in 26 patients patients with Alzheimer's disease (AD) without major clinical signs of undernutrition, and 28 matched controls. CSF zinc levels were significantly decreased in AD patients as compared with controls (p < 0.05). The serum levels of zinc, and the CSF and serum levels of iron, copper, and manganese, did not differ significantly between AD-patient and control groups. These values were not correlated with age, age at onset, duration of the disease, and scores of the MiniMental State Examination in the AD group. Weight and body mass index were significantly lower in AD patients than in controls. Because serum zinc levels were normal, the possibility that low CSF zinc levels were due to a deficiency of dietary intake seems unlikely. However, it is possible that they might be related to the interaction of beta-amyloid and/or amyloid precursor protein with zinc, that could result in a depletion of zinc levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Molina et al. (91) examined 26 AD and 28 control subjects and found a significant decrease in cerebrospinal fluid zinc levels in AD patients.”
From Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease (2013) · cites this paper as [91]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · cited 1×
“Evaluation of each patient included: anamnesis and neurological examination, Mini-Mental State Examination ( Folstein et al., 1975 ), Hachinski Ischemic Score (Hachinski et al., 1975), Hamilton’s Rating Scale for depression (Hamilton, 1969), and laboratory tests (blood cell count, urinalysis, blood routine biochemistr…”
MethodHamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · cited 1×
“B) Criteria for “probable AD” according to the NINCDS-ADRDA Work Group criteria ( McKahnn et al., 1984 ).”
Method. Cerebral blood flow in dementia.
Hachinski, V. C., Iliff, L. D., Zilhka, E., Du Boulay, G. H., McAllister, V. L., Marshall, J., Russell, R. W. R., & Symon, L. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490510088009 · Cited by 3,186 · cited 2×
“Evaluation of each patient included: anamnesis and neurological examination, Mini-Mental State Examination (Folstein et al., 1975), Hachinski Ischemic Score (Hachinski et al., 1975), Hamilton’s Rating Scale for depression (Hamilton, 1969), and laboratory tests (blood cell count, urinalysis, blood routine biochemistry…”
MethodDEXTER, D. T., CARAYON, A., JAVOY-AGID, F., AGID, Y., WELLS, F. R., DANIEL, S. E., LEES, A. J., JENNER, P., & MARSDEN, C. D. (1991) · Brain · doi:10.1093/brain/114.4.1953 · Cited by 1,043
Oxygen radicals and the nervous system
Halliwell, B., & Gutteridge, J. M. C. (1985) · Trends in Neurosciences · doi:10.1016/0166-2236(85)90010-4 · Cited by 819 · cited 1×
“Iron (Halliwell and Gutteridge, 1988), copper (Halliwell and Gutteridge, 1985), and manganese (Donaldson et al., 1992) act as prooxidant agents.”
BackgroundThe Amyloid Precursor Protein of Alzheimer's Disease in the Reduction of Copper(II) to Copper(I)
Multhaup, G., Schlicksupp, A., Hesse, L., Beher, D., Ruppert, T., Masters, C. L., & Beyreuther, K. (1996) · Science · doi:10.1126/science.271.5254.1406 · Cited by 678
Deibel, M. A., Ehmann, W. D., & Markesbery, W. R. (1996) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00203-1 · Cited by 540 · cited 3×
“There have been described decreased copper concentrations in the hippocampus and amygdala (Deibel et al., 1996).”
BackgroundGood, P. F., Perl, D. P., Bierer, L. M., & Schmeidler, J. (1992) · Annals of Neurology · doi:10.1002/ana.410310310 · Cited by 476 · cited 1×
“Iron levels have been described to be increased in the hippocampus (Morris et al., 1994; Deibel et al., 1996), amygdala (Deibel et al., 1996) frontal cortex (Kala et al., 1996; Loeffler et al., 1995), globus pallidus (Loeffler et al., 1995) and cerebellum (Kala et al., 1996), and it has been described accumulation of…”
BackgroundA Selective Increase in Particulate Superoxide Dismutase Activity in Parkinsonian Substantia Nigra
Saggu, H., Cooksey, J., Dexter, D., Wells, F. R., Lees, A., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb11759.x · Cited by 454 · cited 2×
“constituents of the cytosolic Cu/Zn- and the mitochondrial Mn-superoxide dismutases, respectively, which could protect against oxidative processes (Marttila et al., 1988; Saggu et al., 1989).”
Background
Cited by
Items 101–167 of 167
A potential role for zinc alterations in the pathogenesis of Alzheimer's disease
Lyubartseva, G., & Lovell, M. A. (2012) · BioFactors · doi:10.1002/biof.199 · Cited by 33
Ceruloplasmin (2-D PAGE) Pattern and Copper Content in Serum and Brain of Alzheimer Disease Patients
Squitti, R., Quattrocchi, C. C., Forno, G. D., Antuono, P., Wekstein, D. R., Capo, C. R., Salustri, C., & Rossini, P. M. (2006) · Biomarker Insights · doi:10.1177/117727190600100019 · Cited by 33
Kim, K.-R., Park, S. E., Hong, J.-Y., Koh, J., Cho, D., Hwang, J. J., & Kim, Y. H. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.895750 · Cited by 31
“It is known that the concentration of zinc in the blood and cerebrospinal fluid (CSF) decreases with aging, which is accelerated in patients with neurodegenerative diseases including AD and PD (Molina et al., 1998; Du et al., 2017).”
BackgroundRelease of vesicular Zn2+ in a rat transient middle cerebral artery occlusion model
Kitamura, Y., Iida, Y., Abe, J., Mifune, M., Kasuya, F., Ohta, M., Igarashi, K., Saito, Y., & Saji, H. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.03.004 · Cited by 27
Association Between Serum Zinc Levels and the Risk of Parkinson’s Disease: a Meta-Analysis
Sun, H., Liu, X., Ge, H., Wang, T., Wang, Y., & Li, W. (2017) · Biological Trace Element Research · doi:10.1007/s12011-017-0941-2 · Cited by 27
Wallin, C., Luo, J., Jarvet, J., Wärmländer, S. K. T. S., & Gräslund, A. (2016) · Israel Journal of Chemistry · doi:10.1002/ijch.201600105 · Cited by 27
Zinc utilization by microglia in Alzheimer’s disease
Shippy, D. C., Oliai, S. F., & Ulland, T. K. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107306 · Cited by 28
Pamheterozygous mice reveal essential role for Cu in amygdalar behavioral and synaptic function
Gaier, E. D., Eipper, B. A., & Mains, R. E. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12378 · Cited by 25
McIntosh, K. G., Cusack, M. J., Vershinin, A., Chen, Z. W., Zimmerman, E. A., Molho, E., Celmins, D. F., & Parsons, P. J. (2012) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2012.709412 · Cited by 24
Transport of Non-Transferrin Bound Iron to the Brain: Implications for Alzheimer’s Disease
Tripathi, A. K., Karmakar, S., Asthana, A., Ashok, A., Desai, V., Baksi, S., & Singh, N. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170097 · Cited by 24
Michalke, B., Halbach, S., Berthele, A., Mistritiotis, P., & Ochsenkühn-Petropoulou, M. T. (2007) · Journal of Analytical Atomic Spectrometry · doi:10.1039/b610639k · Cited by 25
A Preliminary Study of Metalloproteins in CSF by CapLC-ICPMS and NanoLC-CHIP/ITMS
Ellis, J., Busto, M. E. D. C., Montes‐Bayón, M., Grimm, R., Clark, J. F., Pyne‐Geithman, G. J., Wilbur, S., & Caruso, J. A. (2008) · Journal of Proteome Research · doi:10.1021/pr800024k · Cited by 22
Su, C., Sun, Y., Tzeng, S., Yang, C., Wang, C., & Yang, M.-H. (2009) · Mass Spectrometry Reviews · doi:10.1002/mas.20240 · Cited by 25
Metallomics Applied to the Study of Neurodegenerative and Mental Diseases
Sussulini, A., & Hauser‐Davis, R. A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-90143-5_2 · Cited by 23
Nakagawa, Y., & Yamada, S. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01234-3 · Cited by 20
Upregulation of zinc transporter 2 in the blood–CSF barrier following lead exposure
Fu, X., Zeng, A., Zheng, W., & Du, Y. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213509213 · Cited by 21
“From the clinical point of view, a significantly lower CSF Zn concentration has been found in AD patients than that of matched controls.(10) Constantinidis and colleagues also hypothesize that the formation of Table 1 PE values and PE ratio of Zn and (14)C-sucrose in transwell efflux transport studies”
Progress Towards a Consensus on Biomarkers for Alzheimer‘S Disease: A Review of Peripheral Analytes
Rembach, A., Ryan, T. M., Roberts, B. R., Doecke, J. D., Wilson, W. J., Watt, A. D., Barnham, K. J., & Masters, C. L. (2013) · Biomarkers in Medicine · doi:10.2217/bmm.13.59 · Cited by 20
Nakagawa, Y., & Yamada, S. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107455 · Cited by 18
Romarís, E. M. G., Idoate, I., López, J. M. G., & Marcén, J. F. E. (2010) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2010.10.009 · Cited by 19
In vivo expression of copper-transporting proteins in rat brain regions
Платонова, Н. А., Барабанова, С. В., Povalikhin, R., Васильевна, Ц. Н., Danilovskii, M. A., Voronina, O., Dorokhova, I., & Puchkova, L. V. (2005) · Biology Bulletin · doi:10.1007/s10525-005-0016-3 · Cited by 16
Age-Related Features of Ceruloplasmin Biosynthesis and Distribution in Rats
Платонова, Н. А., Zhiguleva, E. A., Васильевна, Ц. Н., Bs, M., Vasin, A. V., Zhivulko, T., & Puchkova, L. V. (2004) · Russian Journal of Developmental Biology · doi:10.1023/b:rudo.0000029711.35897.6f · Cited by 16
“This is also corroborated by significant changes of the copper and Cp concentrations in CSF fluid at neurodegenerative diseases of different etiology (Kapaki et al., 1997; Molina et al., 1998; Boll et al., 1999).”
BackgroundEstrés oxidativo y enfermedad de Alzheimer
Jiménez, F. J. J., Navarro, H. A., Ayuso‐Peralta, L., & Wadih, T. J. (2006) · Revista de Neurología · doi:10.33588/rn.4207.2005225 · Cited by 28
Henkin, R. I., Velicu, I., Potolicchio, S. J., Levy, L. M., Martin, B. M., & Moharram, R. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181cda0e3 · Cited by 15
Trace element imbalances in blood serum of Alzheimer’s disease patients
Lavanya, R., Reddy, B. S., Sattar, S. A., & Rao, A. D. P. (2021) · Spectroscopy Letters · doi:10.1080/00387010.2021.1941124 · Cited by 14
“Religa et al,[49] Molina et al.[50] could not detect any significant difference in the manganese levels of brain tissue and serum samples respectively between Alzheimer’s disease patients and controls.”
BackgroundInfluentialPande, M. B. S., Nagabhushan, P. N., Hegde, M. L., Rao, T. S., & Rao, K. S. J. (2004) · Computers in Biology and Medicine · doi:10.1016/s0010-4825(04)00064-2 · Cited by 13
López, Á. C., García-Ruiz, E., Resano, M., & Torró, J. L. T. (2017) · Journal of Analytical Atomic Spectrometry · doi:10.1039/c7ja00210f · Cited by 12
Metaxas, A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.755475 · Cited by 13
Biomedical and Pharmaceutical Applications
Sonet, J., Bulteau, A., Chavatte, L., García‐Barrera, T., Gómez‐Ariza, J. L., Leblic, B. C., Nischwitz, V., Theiner, S., Galvez, L., Koellensperger, G., et al. (2016) · Metallomics · doi:10.1002/9783527694907.ch13 · Cited by 12
Cerebrospinal fluid oxidative stress markers in Alzheimer's disease
Sakakibara, R., & Kawai, T. (2020) · Neurology and Clinical Neuroscience · doi:10.1111/ncn3.12413 · Cited by 13
EDTA as a chelating agent in quantitative 1H-NMR of biologically important ions
Mathuthu, E., van Rensburg, A. J., Plessis, D. D., & Mason, S. (2021) · Biochemistry and Cell Biology · doi:10.1139/bcb-2020-0543 · Cited by 12
Elevation of serum copper levels in Alzheimer’s disease
Brenner, S. (2003) · Neurology · doi:10.1212/wnl.60.9.1559 · Cited by 11
Taddeo, M. A., Lee, S., & Shea, T. B. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132696 · Cited by 10
“7 M) [28].”
Kindy, M. S., Yu, J., Zhu, H., Bhat, A. N., El-Sayed, H., Gattoni‐Celli, S., & Gudz, T. I. (2015) · Neuroimmunology and Neuroinflammation · doi:10.4103/2347-8659.149421 · Cited by 10
“said for lead (Pb), mercury (Hg), methylmercury (MeHg), iron (Fe), zinc (Zn), etc.[51-54] The association between”
BackgroundCalcium Disodium Edetate Enhances Type A Monoamine Oxidase Activity in Monkey Brain
Egashira, T., Sakai, K., Sakurai, M., & Takayama, F. (2003) · Biological Trace Element Research · doi:10.1385/bter:94:3:203 · Cited by 10
“From these reports and our data, because zinc is known to be present in the brain and in cerebrospinal fluid (20,21), Zn may act as an endogenous type-A MAO inhibitor and regulate the functions of MAO-A in serotonergic neurons in the central nervous system.”
BackgroundCosan, T. E., Demir, T. A., Yayla, E., Coşan, D. T., Berber, A., & Kaynak, Z. (2006) · Acta Neurochirurgica · doi:10.1007/s00701-006-0745-1 · Cited by 8
“neurological disorders [7–9, 15].”
Powell, L. R., Dukes, K. D., & Lammi, R. K. (2011) · Biophysical Chemistry · doi:10.1016/j.bpc.2011.08.006 · Cited by 10
“The acidic conditions mimic those of early endosomes where Aβ is produced [51, 52] and the zinc concentrations used are within the range observed in the brain [53–55], where zinc release during neurotransmission (at concentrations up to 300 μM [54, 55]) may cause Aβ oligomers to target synapses [56].”
BackgroundRegulation of Neuroactive Metals by the Choroid Plexus
Li, G. J., & Zheng, W. (2005) · CRC Press eBooks · doi:10.1201/9781420023404.ch9 · Cited by 9
“A more recent study indicated that CSF Zn level is significantly decreased in AD as compared to the age-matched controls (Molina et al., 1998).”
ResultGonzález‐Domínguez, R. (2017) · Neuromethods · doi:10.1007/978-1-4939-6918-0_8 · Cited by 7
Hobin, K., Costas‐Rodríguez, M., Wonterghem, E. V., Vandenbroucke, R. E., & Vanhaecke, F. (2024) · Analytica Chimica Acta · doi:10.1016/j.aca.2024.342812 · Cited by 6
Metal Ions and Alzheimer's Disease
Adlard, P. A., & Bush, A. I. (2007) · Springer eBooks · doi:10.1007/978-0-387-70830-0_15 · Cited by 6
“While there have been a number of studies examining the presence of metal ions in both the serum and CSF of AD patients, there is little consistency among studies, although most show decreases in metal ions (Basun et al., 1991; Molina et al., 1998).”
BackgroundZinc and Alzheimer's Disease: An Update
Cuajungco, M. P., Lees, G. J., Kydd, R. R., Tanzi, R. E., & Bush, A. I. (1999) · Nutritional Neuroscience · doi:10.1080/1028415x.1999.11747277 · Cited by 7
Mesa-Herrera, F., Marín, R., Torrealba, E., & Díaz, M. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215437 · Cited by 5
Effects of taurine on metal cations, transthyretin and LRP-1 in a rat model of Alzheimer’s disease
Tekin, E., Karakelle, N. A., & Dinçer, S. (2023) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2023.127219 · Cited by 6
Rösler, N., Wichart, I., & Jellinger, K. A. (2002) · Journal of Laboratory Medicine · doi:10.1046/j.1439-0477.2002.02031.x · Cited by 11
Nutrient‐sensing amyloid metastasis
Lima, L. M. T. R., & Sisnande, T. (2022) · BioFactors · doi:10.1002/biof.1825 · Cited by 5
“Among the essential trace elements, Zn levels in the CSF of Alzheimer patients are low compared with individuals free of the disease, although their serum levels are similar to matched controls.(177,178) Elevation in Mn levels in CSF was found to be correlated with AD and PD patients.”
ResultSun, Y., & Ho, M.-C. (2004) · Journal of Analytical Atomic Spectrometry · doi:10.1039/b408978b · Cited by 5
Zinc in Alzheimer’s and Parkinson’s Diseases
Ayton, S., Finkelstein, D. I., Cherny, R. A., Bush, A. I., & Adlard, P. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-1533-6_214 · Cited by 5
HACIŞEVKİ, K. E. (2008) · Ankara Universitesi Eczacilik Fakultesi Dergisi · doi:10.1501/eczfak_0000000495 · Cited by 3
“An appreciable number of human diseases are related to iron deficiency or disorders of iron metabolism (9, 11).”
BackgroundResultAge-Related Oxidative Stress-Induced Redox Imbalance
Tan, B. L., & Norhaizan, M. E. (2021) · Springer eBooks · doi:10.1007/978-3-030-82859-2_3 · Cited by 4
Effects of zinc ion on type A monoamine oxidase in monkey brain mitochondria
Egashira, T., Takayama, F., & Sakai, K. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01608-8 · Cited by 3
Buczkowska, M. (2011) · Cited by 3
Metals and Mitochondria in Neurodegeneration
Plascencia‐Villa, G., José–Yacamán, M., & Perry, G. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804562-6.00015-4 · Cited by 3
Lovell, M. A. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-7104-3_20 · Cited by 2
Cerebrospinal fluid biomarkers for neurodegenerative disorders
Videira, R. M. A. S. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 3
Evaluation of polypropylene CSF low-bind collection tubes for trace metal contamination
Bitzer, A. C., Jannetto, P. J., & Bornhorst, J. A. (2024) · Laboratory Medicine · doi:10.1093/labmed/lmae067 · Cited by 1
Metals Involvement in Alzheimer’s Disease Pathogenesis
Squitti, R., & Salustri, C. (2011) · InTech eBooks · doi:10.5772/16880 · Cited by 1
“…et al., 2008), many others no variation (Basun et al., 1991, Baum et al., 2010, Gerhardsson et al., 2008, Jeandel et al., 1989, Kapaki et al., 1989, Molina et al., 1998, Ozcankaya & Delibas, 2002, Snaedal et al., 1998), and two very recent studies even a decrease of copper in plasma (Vural et al.,…”
BackgroundLiu, M. J., & Knoell, D. L. (2014) · Springer eBooks · doi:10.1007/978-4-431-55114-0_11 · Cited by 1
“paradigm is that bioavailabile pools of Zn, or a lack thereof, may regulate the immune response and inflammation in the brain: this is based on previous studies that have revealed abnormally low Zn levels within key compartments of the brain (Molina et al. 1998; Kapaki et al. 1989).”
BackgroundALTERATIONS OF ZINC TRANSPORTERS IN ALZHEIMER'S DISEASE
Lyubartseva, G. (2009) · UKnowledge (University of Kentucky)
Copper and zinc in Alzheimer's disease and amyotrophic lateral sclerosis
Friedlich, A. L., & Bush, A. I. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544873.014
Copper, Zinc, and Alzheimer’s Disease
Friedlich, A. L., Nagano, S., & Bush, A. I. (2002) · Springer eBooks · doi:10.1007/978-1-4615-1067-3_14
Marquis, K. A., Spottiswoode, N., Detweiler, A. M., Neff, N. F., & DeRisi, J. L. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1014783
Effects of zinc and copper ions in the amyloid cascade linked to Alzheimer's disease
Borghesani, V. (2018) · theses.fr (ABES) · doi:10.70675/d82c3f9az0deaz45e9z9097zeb1f4fd0a45b
Role of synaptic zinc in pathophysiology of Parkinson’s disease
Sikora, J. (2020) · theses.fr (ABES) · doi:10.70675/87e4f747zbcf8z45aaz8541z50965800f3c6
Copper isotope shifts in biofluids track Alzheimer's pathology
Lahoud, E., Moynier, F., Mahan, B., Luu, T.-H., Rigoussen, D., Borgne, M. L., Paquet, C., Fowler, C. J., & Bush, A. I. (2026) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70316
Introduction to Brain Metallomics and Its Relevance to Neuroscience
Lowe, N. M., & Grabrucker, A. M. (2026) · Neuromethods · doi:10.1007/978-1-0716-5468-2_2
Impact of stress exposure and pharmacological intervention on a mouse model of Alzheimer’s disease
Sierksma, S. R. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20121220ss
Metadata
- Authors
- Molina, J. A., Jiménez-Jiménez, F. J., Aguilar, M. V., Meseguer, I., Mateos-Vega, C. J., González-Muñoz, M. J., de Bustos, F., Porta, J., Ortí-Pareja, M., Zurdo, M., Barrios, E., & Martínez-Para, M. C.
- Affiliations
- Hospital Universitario 12 De Octubre (ES)
- Hospital Universitario Príncipe de Asturias (ES)
- Universidad de Alcalá (ES)
- Venue
- Journal of Neural Transmission
- Published
- 1998
- Volume
- 105
- Issue
- 4
- Pages
- 479
- ISSN
- 0300-9564 (ISSN-L)
- OpenAlex
- W2007947235
- Cited by
- 167
- References
- 50
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 5 · 2021: 5 · 2020: 5 · 2019: 3 · 2018: 5 · 2017: 14 · 2016: 6 · 2015: 6 · 2014: 5 · 2013: 15 · 2012: 12
- FWCI
- 0.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neural Transmission (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, cerebrospinal fluid, transition metals, zinc, iron, copper, manganese, serum metal levels, metal deficiency, amyloid-beta, amyloid precursor protein, body mass index, malnutrition
- MeSH terms
- Aged, Alzheimer Disease, Blood Proteins, Copper, Female, Humans, Iron, Male, Manganese, Nutritional Status, Reference Values, Spectrophotometry, Atomic, Trace Elements, Vitamin A, Zinc, Metals, Heavy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.